One of the most important launches for Novartis in recent years is off with a bang. Following a broad FDA approval for the adjuvant treatment of HR-positive, HER2-negative early breast cancer in ...

Susvimo 100 mg/mL for intravitreal use via ocular implant is a refillable implant surgically inserted into the eye during a ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug ...

Genentech, a member of the Roche Group (RHHBY), announced that the U.S. Food and Drug Administration has approved Susvimo ...

The FDA approved Susvimo for the treatment of diabetic macular edema, according to a press release. The decision was supported by positive 1-year data from the phase 3 Pagoda study, in which Susvimo ...

Eli Lilly’s Verzenio is already one of its fastest-growing products, but could go up another gear following a pair of FDA approvals that expand its eligible patient population – particularly ...

There's nothing quite like curling up with a great book on a cold winter's day –– and with the right reading tablet, your entire library is always within reach. You can choose from the ...

The right drawing tablet can make all the difference in bringing your creative vision to life. It should feel like an extension of your hand, translating every brushstroke with precision and fluidity.

These relatively new approvals join a lineup of several older medicines whose sales are still growing at a good clip, including immunosuppressant Taltz, cancer drug Verzenio, and fast-acting ...

Most of the tablets included in this guide are older-generation models, so you may have to visit third-party retailers to pick them up, but where possible, we've provided links to those retailers ...

Genentech unit has received FDA approval for its drug Susvimo 100 mg/mL injection for the treatment of diabetic macular edema, a leading cause of blindness for people with diabetes. Susvimo, also ...

The MG4 is a darling in the EV world. Available at an attractive price and offering a comfortable rear-wheel drivetrain, this hatchback stands up against heavy hitters from Tesla, Hyundai and Kia.